[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100112852":3},{"organization":4,"armGroups":7,"interventions":17,"overallOfficials":11,"centralContacts":11,"locations":38,"responsibleParty":118,"collaborators":11,"id":120,"slug":121,"hasResults":122,"nctId":123,"briefTitle":124,"officialTitle":125,"acronym":126,"eligibilityCriteria":127,"healthyVolunteers":128,"sex":129,"minAge":130,"maxAge":11,"enrollmentInfo":131,"targetDuration":11,"studyType":134,"phases":135,"briefSummary":137,"conditions":138,"keywords":140,"overallStatus":146,"whyStopped":11,"lastUpdateSubmitDate":147,"lastUpdatePostDateStruct":148,"startDateStruct":151,"completionDateStruct":153,"leadSponsor":155,"locationsCount":156},{"fullName":5,"class":6},"AstraZeneca","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Nexium 40 mgs","EXPERIMENTAL",null,[13,14,15,16],"Drug: Esomeprazole 40 mg","Procedure: Physical Exam","Other: Quality of Life Questionnaires","Procedure: pregnancy test, if applicable",[18,25,30,34],{"type":19,"name":20,"description":21,"armGroupLabels":22,"otherNames":23},"DRUG","Esomeprazole 40 mg","Once a day",[9],[24],"Nexium",{"type":26,"name":27,"description":28,"armGroupLabels":29,"otherNames":11},"PROCEDURE","Physical Exam","every visit",[9],{"type":31,"name":32,"description":28,"armGroupLabels":33,"otherNames":11},"OTHER","Quality of Life Questionnaires",[9],{"type":26,"name":35,"description":36,"armGroupLabels":37,"otherNames":11},"pregnancy test, if applicable","as needed",[9],[39,50,59,66,73,82,89,96,104,111],{"facility":40,"status":11,"city":41,"state":11,"zip":11,"country":42,"countryCode":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":11},"Research Site","Buenos Aires","Argentina","AR",{"type":45,"coordinates":46},"Point",[47,48],-58.37723,-34.61315,{"lat":48,"lon":47},{"facility":40,"status":11,"city":51,"state":11,"zip":11,"country":52,"countryCode":53,"cosmosGeoPoint":54,"geoPoint":58,"contacts":11},"Santiago","Chile","CL",{"type":45,"coordinates":55},[56,57],-70.64827,-33.45694,{"lat":57,"lon":56},{"facility":40,"status":11,"city":60,"state":11,"zip":11,"country":52,"countryCode":53,"cosmosGeoPoint":61,"geoPoint":65,"contacts":11},"Temuco",{"type":45,"coordinates":62},[63,64],-72.59738,-38.73628,{"lat":64,"lon":63},{"facility":40,"status":11,"city":67,"state":11,"zip":11,"country":52,"countryCode":53,"cosmosGeoPoint":68,"geoPoint":72,"contacts":11},"Viña del Mar",{"type":45,"coordinates":69},[70,71],-71.55183,-33.02457,{"lat":71,"lon":70},{"facility":40,"status":11,"city":74,"state":11,"zip":11,"country":75,"countryCode":76,"cosmosGeoPoint":77,"geoPoint":81,"contacts":11},"Barranquilla","Colombia","CO",{"type":45,"coordinates":78},[79,80],-74.78132,10.96854,{"lat":80,"lon":79},{"facility":40,"status":11,"city":83,"state":11,"zip":11,"country":75,"countryCode":76,"cosmosGeoPoint":84,"geoPoint":88,"contacts":11},"Bogotá",{"type":45,"coordinates":85},[86,87],-74.08175,4.60971,{"lat":87,"lon":86},{"facility":40,"status":11,"city":90,"state":11,"zip":11,"country":75,"countryCode":76,"cosmosGeoPoint":91,"geoPoint":95,"contacts":11},"Medellín",{"type":45,"coordinates":92},[93,94],-75.57151,6.245,{"lat":94,"lon":93},{"facility":40,"status":11,"city":97,"state":11,"zip":11,"country":98,"countryCode":11,"cosmosGeoPoint":99,"geoPoint":103,"contacts":11},"Barquisimeto","Venezuela",{"type":45,"coordinates":100},[101,102],-69.35703,10.0647,{"lat":102,"lon":101},{"facility":40,"status":11,"city":105,"state":11,"zip":11,"country":98,"countryCode":11,"cosmosGeoPoint":106,"geoPoint":110,"contacts":11},"Caracas",{"type":45,"coordinates":107},[108,109],-66.87919,10.48801,{"lat":109,"lon":108},{"facility":40,"status":11,"city":112,"state":11,"zip":11,"country":98,"countryCode":11,"cosmosGeoPoint":113,"geoPoint":117,"contacts":11},"San Cristóbal",{"type":45,"coordinates":114},[115,116],-72.23576,7.76593,{"lat":116,"lon":115},{"type":119,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100112852","phase-4-a-study-of-nexium-esomeprazole-40-mg-once-daily-in-subjects-with-symptoms-of-gastroesophageal-reflux-disease-gord-after-treatment-with-a-full-dose-of-proton-pump-inhibitor-ppi-100112852",true,"NCT00734097","A Study of Nexium (Esomeprazole) 40 mg Once Daily in Subjects With Symptoms of Gastroesophageal Reflux Disease (GORD) After Treatment With a Full Dose of Proton Pump Inhibitor (PPI)","An Open Label, Multicentre Study of Nexium (Esomeprazole) 40 mg Once Daily in Subjects With Symptoms of Gastroesophageal Reflux Disease (GORD) After Treatment With a Full Dose of Proton Pump Inhibitor (PPI)","NEON","Inclusion Criteria:\n\n* Persisting symptoms of GORD despite previous treatment with a full dose proton pump inhibitor\n* informed consent\n* over 18 years of age\n\nExclusion Criteria:\n\n* Current course of Proton Pump inhibitor treatment for more than 8 weeks prior to enrolment in the study\n* More than 1 other course of PPI treatment in the previous 12 month\n* previous use of esomeprazole\n* presence of alarm symptoms",false,"ALL","18 Years",{"count":132,"type":133},314,"ACTUAL","INTERVENTIONAL",[136],"PHASE4","The purpose of this study is to assess how patients with gastro-oesophageal reflux disease (heartburn) who are currently receiving treatment with a proton pump inhibitor but are still experiencing symptoms will benefit from a change in treatment.",[139],"Gastroesophageal Reflux Disease",[141,142,143,144,145],"heartburn","reflux","proton","pump","inhibitor","COMPLETED","2012-09-10",{"date":149,"type":150},"2012-10-10","ESTIMATED",{"date":152,"type":11},"2007-11",{"date":154,"type":133},"2008-10",{"name":5,"class":6},10]